[go: up one dir, main page]

FR3007652B1 - COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE - Google Patents

COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE

Info

Publication number
FR3007652B1
FR3007652B1 FR1356342A FR1356342A FR3007652B1 FR 3007652 B1 FR3007652 B1 FR 3007652B1 FR 1356342 A FR1356342 A FR 1356342A FR 1356342 A FR1356342 A FR 1356342A FR 3007652 B1 FR3007652 B1 FR 3007652B1
Authority
FR
France
Prior art keywords
composition
docosahexaenoic acid
pentaerythrityl tetra
butyl hydroxyhydrocinnamate
hydroxyhydrocinnamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1356342A
Other languages
French (fr)
Other versions
FR3007652A1 (en
Inventor
Cyril Chevalier
Thierry Cotton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1356342A priority Critical patent/FR3007652B1/en
Publication of FR3007652A1 publication Critical patent/FR3007652A1/en
Application granted granted Critical
Publication of FR3007652B1 publication Critical patent/FR3007652B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
FR1356342A 2013-06-28 2013-06-28 COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE Expired - Fee Related FR3007652B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1356342A FR3007652B1 (en) 2013-06-28 2013-06-28 COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1356342A FR3007652B1 (en) 2013-06-28 2013-06-28 COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE

Publications (2)

Publication Number Publication Date
FR3007652A1 FR3007652A1 (en) 2015-01-02
FR3007652B1 true FR3007652B1 (en) 2015-07-17

Family

ID=49667278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1356342A Expired - Fee Related FR3007652B1 (en) 2013-06-28 2013-06-28 COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE

Country Status (1)

Country Link
FR (1) FR3007652B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3073741B1 (en) 2017-11-20 2019-10-18 Jean-Noel Thorel STABILIZING COSMETIC COMPOSITION FOR REDUCING THE DEGRADATION OF UNSTABLE COSMETIC ASSETS
FR3104977B1 (en) * 2019-12-20 2023-05-05 Oreal Retinol Serum
FR3104975B1 (en) * 2019-12-20 2021-12-17 Oreal Retinol-based composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE347607T1 (en) * 1996-07-23 2006-12-15 Nagase Chemtex Corp METHOD FOR PRODUCING DECOSAHEXAENIC ACID AND DECOSAPENTIC ACID
US6846942B2 (en) * 2003-05-20 2005-01-25 David Rubin Method for preparing pure EPA and pure DHA
ES2319535T3 (en) * 2003-10-21 2009-05-08 Dsm Ip Assets B.V. STABILIZATION OF CONCENTRATES OF POLYINSATURATED FATTY ACID ESTERS (PUFA).
DE102004062141A1 (en) * 2004-12-23 2006-07-06 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Process for the preparation of a crude oil from mixtures of microorganisms and plants, the oil thus produced and the specific uses of the thus prepared and optionally additionally refined oil

Also Published As

Publication number Publication date
FR3007652A1 (en) 2015-01-02

Similar Documents

Publication Publication Date Title
FR25C1033I1 (en) COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF TTR
EP2934505A4 (en) EICOSAPENTAENOIC ACID FORMULATIONS (EPA)
EP3763364C0 (en) Self-emulsifying omega-3 fatty acid composition
HRP20181418T1 (en) DPA-Enriched Preparations of Omega-3 Polyunsaturated Fatty Acids in the Form of Free Acid
EP2861227A4 (en) OMEGA-3 PENTANOIC ACID COMPOSITIONS AND METHODS OF USE
DK3072510T3 (en) Omega-3-fatty acid ester COMPOSITIONS
EP2903939A4 (en) STABLE CARBOXYLIC ACID COMPOSITIONS AND USES THEREOF
EP2915557A4 (en) MICRO-NEEDLE OF RETINOIC ACID
EP2970086A4 (en) RECOVERY OF 3-HYDROXYPROPIONIC ACID
EP2910600A4 (en) CELLULOSE ESTER COMPOSITION
EP2968137A4 (en) EMULSION FORMULATIONS
FR3015290B1 (en) HYALURONIC ACID COMPOSITIONS COMPRISING MEPIVACAINE
FR3012959B1 (en) COSMETIC COMPOSITION COMPRISING SPICULISPORIC ACID AND AT LEAST ONE SURFACTANT
EP2970325A4 (en) LYSOPHOSPHATIDE ACID DETECTION
DK2860211T3 (en) PHOSPHORIC ACID ESTER PREPARATIONS WITH DEGRADED HYGROscopy
EP2947141A4 (en) MICROORGANISMS PRODUCING DOCOSAHEXAENOIC ACID AND THEIR USE
HUE046239T2 (en) Mixtures of fatty acids for use in the treatment of inflammatory diseases
EP2753336A4 (en) COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER
EP2999476A4 (en) MORPHIC FORMS OF HEXADECYLOXYPROPYL-PHOSPHONATE ESTERS
FR2988103B1 (en) PRODUCTION OF DOCOSAHEXAENOIC ACID AND / OR EICOSAPENTAENOIC ACID AND / OR CAROTENOID (S) IN MIXOTROPHE MODE BY NITZSCHIA
EP2975408A4 (en) EXAM KIT
EP2981256A4 (en) SYNTHETIC ANTI-INFLAMMATORY COMBINATIONS COMPRISING OMEGA-3 FATTY ACID AND TOMATO LYCOPENE
EP2849571A4 (en) MODIFIED TALLÖL FATTY ACID
HUE040027T2 (en) Taurourodoxycolic acid (TUDCA) for use in the treatment of neurodegenerative diseases
EP2868324A4 (en) HYALURONIC ACID DECOMPOSITION INHIBITOR COMPRISING ROSEMARY EXTRACT AND RETINOL ACETATE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20220205